Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guidel
about
Chemotherapy regimens for metastatic nonsmall cell lung cancer: Generating good quality data is important before challenging evidence.Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLCCombined modality therapy in Stage IIIA non-small cell lung cancer: clarity or confusion despite the highest level of evidence?Efficacy of postoperative radiotherapy in patients with pathological stage N2 epidermal growth factor receptor wild type adenocarcinoma and squamous cell carcinoma lung cancerThe effect of induction chemotherapy in patients with locally advanced nonsmall cell lung cancer who received chemoradiotherapy: A systematic review and meta-analysis.Pros: concurrent chemo-radiotherapy remains the ideal treatment in fit patients with large volume unresectable stage III non-small cell lung cancer.Optimal sequencing of adjuvant chemotherapy and radiation therapy in resected non-small cell lung cancer with pathological N2 diseaseRepression of the autophagic response sensitises lung cancer cells to radiation and chemotherapy.Tumor suppressor miR-29c regulates radioresistance in lung cancer cells.Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839.Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibitionMultimodality Therapy for NSCLC.Rebuttal from Prof. Kong and Dr. Rabatic.Cons: concurrent chemo-radiotherapy remains the ideal treatment in fit patients with inoperable large volume stage III non-small cell lung cancer.Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients.Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials.Early postoperative radiotherapy is associated with improved outcomes over late postoperative radiotherapy in the management of completely resected (R0) Stage IIIA-N2 non-small cell lung cancer.Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer.Battling regional (stage III) lung cancer: bumpy road of a cancer survivor in the immunotherapy age.An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small cell lung cancer.Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation.Meet the new boss: lung cancer staging.Durvalumab: a potential maintenance therapy in surgery-ineligible non-small-cell lung cancer.
P2860
Q31125762-019D5D33-BD29-435B-B8EB-CEBC9434FFA4Q33584618-CC61C1F0-E02D-4083-9BE8-6C980B44197EQ33716531-6E83FAF9-1B73-40B7-B6FB-F427FEE1F3B3Q33798819-0074CAD3-C2E4-4B2D-A5DB-8F7BDD3BA686Q36287297-53DB8CED-6280-4E00-B0F4-C20F7B21C15AQ36874790-0FF0B367-B6A7-48CC-80FA-918675213FB0Q36948943-8D3A8749-11E8-4375-AE8F-808DC9F651D4Q37151103-7FE5A947-71F3-415C-BE09-D3EF0FD6F14BQ38435405-CD9AEA86-274C-4F4B-8246-93F8B1D7E406Q38718558-69524424-A231-471E-8909-E61698A19095Q38823644-B72B8813-0AF7-46CB-9D13-527ACFDFBD80Q38930358-BFE50666-664C-40B8-B24F-D443D0B6255EQ41081446-26A6AD82-8259-4FF0-834B-BF40605BB449Q41081663-0F334A1C-F35A-4FEE-BC0D-FE5DD0FCF57AQ41201725-88261987-A970-4432-816F-185107F51EEBQ41339882-E8221C0B-0E30-4BF1-9B19-8933D6EA7A85Q42362645-975F4017-FB0B-4A12-BAF1-F5DE381A6E38Q47643885-3E20B72C-5125-40B8-AA22-5FCF5037BC3DQ51655915-1C403F9A-E681-44EB-862D-0B5ECC6D4BB1Q52863753-98110F7D-DDF3-4C3F-9AF0-7D4384ED750AQ52878867-EACDF396-D75D-457F-B20E-4AC2F15F2097Q55208721-EEF95C20-F01A-4254-BA22-E88C0DCCA1EFQ55304879-5145EDD4-4DC6-4AD9-BCCF-DD6D9A658564
P2860
Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guidel
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Definitive and Adjuvant Radiot ...... Based Clinical Practice Guidel
@en
type
label
Definitive and Adjuvant Radiot ...... Based Clinical Practice Guidel
@en
prefLabel
Definitive and Adjuvant Radiot ...... Based Clinical Practice Guidel
@en
P2093
P356
P1476
Definitive and Adjuvant Radiot ...... Based Clinical Practice Guidel
@en
P2093
Andrea Bezjak
Andreas Rimner
Bryan J Schneider
Christopher G Azzoli
Gregg Franklin
John Strawn
Melissa L Johnson
Ramaswamy Govindan
Sarah Temin
P304
P356
10.1200/JCO.2014.59.2360
P407
P577
2015-05-05T00:00:00Z